| Product Name | NebuSelect™ Recombinant Human Glypican 1/GPC1, His-tag |
|---|---|
| Catalog Number | NBL-242563 |
| Alias/Synonyms | Glypican 1/GPC1; Glypican-1; FLJ38078; GPC1 |
| Appearance | see COA |
| Molecule Weight | |
| CAS | N/A |
| Solubility | Water Soluble |
| Storage | Short term 4℃; Long term -20℃. |
| Shelf Life | 2 years |
| Additional info 1 | P35052-1 |
| Additional info 2 |
| Catalog Numbe | Size | Price | Inventory Level | |
| NBL-242563-100ug | 100ug | Inquire | Inquire | |
| NBL-242563-1mg | 1mg | Inquire | Inquire | |
| NBL-242563-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Human Glypican 1/GPC1, His-tag
Catalog#:
NBL-242563
Description:
NebuSelect™ Recombinant Human Glypican 1/GPC1, His-tag(Cat#NBL-242563) is expressed in HEK293 with His tag at the C-Terminus.It contains Asp24-Ser530.
Species:
Human
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 57.1 kDa. Due to glycosylation, the protein migrates to 70-135 kDa based on Bis-Tris PAGE result.
Target Name:
Glypican 1/GPC1; Glypican-1; FLJ38078; GPC1
Target Information:
CAR-T cells targeting glypican-1 (GPC1)-specific human and murine CAR-T cells generated from our original anti-human/mouse GPC1 antibody showed strong antitumor effects in xenogeneic and syngeneic mouse models, respectively. Importantly, the murine CAR-T cells enhanced endogenous T cell responses against a non-GPC1 tumor antigen through the mechanism of antigen-spreading and showed synergistic antitumor effects with anti-PD-1 antibody without any adverse effects in syngeneic models.
Amino Acid Sequence:
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.